Clinical Trial Update: Romiplostim Versus rhTPO for Platelet Engraftment After Transplant in MDS and AA [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial compares romiplostim to recombinant human thrombopoietin (rhTPO) for platelet engraftment after transplantation in patients with myelod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Myelodysplastic Syndrome

Drugs mentioned

• Nplate (romiplostim)
• rhTPO (recombinant human thrombopoietin)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: MDS (Myelodysplastic Syndrome), Aplastic Anemia (AA) | Phase 2 | Status: RECRUITING